Cremonesi AInterventional Cardiovascular Unit, GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy cremonesi.a@gmail.com acremonesi@gvmnet.it cremonesialberto@hotmail.com.
Castriota FInterventional Cardiovascular Unit, GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy.
Secco GGMaggiore Della Carità Hospital, University of Eastern Piedmont, Novara, Italy.
Macdonald SDepartment of Radiology, Freeman Hospital, Newcastle upon Tyne, UK.
Roffi MDivision of Cardiology, University Hospital, Geneva, Switzerland.
English
In patients with carotid disease, the purpose of carotid artery revascularization is stroke prevention. For >50 years, carotid endarterectomy has been considered the standard treatment for severe asymptomatic and symptomatic carotid stenoses. Carotid artery stenting (CAS) has emerged in the last 15 years as minimally invasive alternative to surgery. However, the value of the endovascular approach in the management of carotid disease patients remains highly controversial. The aims of this review are to elucidate the current role of CAS, to describe the major technology advancements in the field, and to speculate about the future of this therapy.